CA Stock MarketDetailed Quotes

MDMA Pharmala Biotech Holdings Inc

Watchlist

0.290
-0.010-3.33%

15min DelayMarket Closed Jan 8 15:59 ET

27.34MMarket Cap-29.00P/E (TTM)

Pharmala Biotech Holdings Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Aug 31, 2024

(Q2)Feb 29, 2024

(Q1)Nov 30, 2023

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(Q3)May 31, 2023

(Q2)Feb 28, 2023

(Q1)Nov 30, 2022

(FY)Aug 31, 2022

(Q4)Aug 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

115.02%419.38K

-94.49%40.35K

-69.49%222.85K

-77.11%195.04K

-58.70%495.99K

-60.42%731.72K

-65.98%730.47K

-65.53%852.14K

--852.14K

-Cash and cash equivalents

115.02%419.38K

-94.49%40.35K

-69.49%222.85K

-77.11%195.04K

-58.70%495.99K

-60.42%731.72K

-65.98%730.47K

-65.53%852.14K

--852.14K

Receivables

-5.42%211.38K

361.92%395.01K

127.10%285.39K

342.11%223.49K

-60.18%27.91K

-29.12%85.52K

56.72%125.67K

-15.15%50.55K

--50.55K

-Accounts receivable

44.73%200.89K

85.68%112.95K

68.45%123.68K

497.88%138.8K

--0

-35.97%60.83K

--73.43K

--23.22K

-Taxes receivable

10.08%27K

268.53%76.24K

-3.17%46.71K

5.13%24.53K

-63.82%23.91K

-4.41%20.69K

-36.68%48.24K

-58.02%23.33K

--23.33K

-Other receivables

-70.20%22.95K

5,467.33%222.69K

3,196.38%131.86K

1,825.43%77.02K

0.00%4K

--4K

-Recievables adjustments allowances

-134.02%-39.46K

---16.86K

----

Inventory

189.33%353.53K

-91.27%10.16K

5.03%122.19K

92.16%218.13K

--116.34K

Prepaid assets

-65.85%59.15K

195.98%236.04K

365.83%129.07K

160.72%173.23K

47.91%86.46K

-6.47%79.75K

261.02%27.71K

--66.44K

Total current assets

46.15%1.04M

-32.74%681.56K

-35.27%647.47K

-34.23%713.95K

-42.58%828.5K

-50.68%1.01M

-55.25%1M

-57.13%1.09M

--1.09M

Non current assets

Net PPE

-80.92%401

-57.30%1.26K

-50.41%1.67K

-44.67%2.1K

-39.90%2.53K

-36.56%2.95K

-33.80%3.38K

60.70%3.8K

--3.8K

-Gross PPE

0.00%5.66K

112.07%5.66K

--5.66K

-Accumulated depreciation

-47.86%-5.26K

-62.60%-4.4K

-74.65%-3.98K

-91.38%-3.55K

-116.18%-3.13K

-170.03%-2.7K

-310.07%-2.28K

-512.87%-1.86K

---1.86K

Goodwill and other intangible assets

9.31%1.85M

30.28%1.8M

28.88%1.74M

36.72%1.7M

74.69%1.44M

135.37%1.38M

334.98%1.35M

378.12%1.24M

--1.24M

-Other intangible assets

9.31%1.85M

30.28%1.8M

28.88%1.74M

--1.7M

--1.44M

--1.38M

--1.35M

----

Total non current assets

9.20%1.85M

30.09%1.8M

28.68%1.74M

36.47%1.7M

74.10%1.44M

134.02%1.38M

329.01%1.35M

375.26%1.24M

--1.24M

Total assets

20.13%2.9M

3.52%2.48M

1.48%2.39M

3.54%2.41M

-0.02%2.27M

-9.41%2.4M

-7.77%2.35M

-16.60%2.33M

--2.33M

Liabilities

Current liabilities

Payables

14.08%358.19K

----

--313.98K

----

-accounts payable

14.08%358.19K

----

--313.98K

----

Current accrued expenses

-29.08%192.7K

----

--271.72K

----

Current deferred liabilities

-17.44%366K

18.56%399.07K

-12.24%283.19K

750.55%443.32K

--387.58K

7,827.23%336.59K

7,501.32%322.68K

--52.12K

Current liabilities

-10.90%916.88K

50.98%1.14M

26.64%878K

142.82%1.03M

171.51%812.35K

56.49%753.89K

417.80%693.3K

206.03%423.78K

--423.78K

Non current liabilities

Total non current liabilities

--0

Total liabilities

-10.90%916.88K

50.98%1.14M

26.64%878K

142.82%1.03M

171.51%812.35K

56.49%753.89K

417.80%693.3K

206.03%423.78K

--423.78K

Shareholders'equity

Share capital

10.80%5.69M

8.90%5.26M

6.37%5.14M

0.00%4.83M

120.03%4.83M

--4.83M

-common stock

10.80%5.69M

8.90%5.26M

6.37%5.14M

0.00%4.83M

120.03%4.83M

--4.83M

Additional paid-in capital

129.03%861.97K

-8.56%399.73K

-18.28%343.14K

-0.74%376.36K

46.32%371.09K

82.80%437.15K

103.73%419.9K

165.85%379.15K

--379.15K

Retained earnings

-19.93%-4.96M

-16.30%-4.32M

-8.27%-4.1M

-18.25%-4.13M

-22.67%-4.05M

-19.90%-3.71M

-34.55%-3.78M

-39.28%-3.49M

---3.49M

Other equity interest

--380.58K

----

-54.14%87.26K

0.00%190.27K

-93.27%190.27K

--190.27K

Total stockholders'equity

43.21%1.98M

-18.25%1.34M

-9.03%1.51M

-27.42%1.38M

-26.05%1.46M

-24.09%1.64M

-31.35%1.66M

-28.21%1.91M

--1.91M

Total equity

43.21%1.98M

-18.25%1.34M

-9.03%1.51M

-27.42%1.38M

-26.05%1.46M

-24.09%1.64M

-31.35%1.66M

-28.21%1.91M

--1.91M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Aug 31, 2024	(Q2)Feb 29, 2024	(Q1)Nov 30, 2023	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(Q3)May 31, 2023	(Q2)Feb 28, 2023	(Q1)Nov 30, 2022	(FY)Aug 31, 2022	(Q4)Aug 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	115.02%419.38K	-94.49%40.35K	-69.49%222.85K	-77.11%195.04K	-77.11%195.04K	-58.70%495.99K	-60.42%731.72K	-65.98%730.47K	-65.53%852.14K	--852.14K
-Cash and cash equivalents	115.02%419.38K	-94.49%40.35K	-69.49%222.85K	-77.11%195.04K	-77.11%195.04K	-58.70%495.99K	-60.42%731.72K	-65.98%730.47K	-65.53%852.14K	--852.14K
Receivables	-5.42%211.38K	361.92%395.01K	127.10%285.39K	342.11%223.49K	342.11%223.49K	-60.18%27.91K	-29.12%85.52K	56.72%125.67K	-15.15%50.55K	--50.55K
-Accounts receivable	44.73%200.89K	85.68%112.95K	68.45%123.68K	497.88%138.8K	497.88%138.8K	--0	-35.97%60.83K	--73.43K	--23.22K	--23.22K
-Taxes receivable	10.08%27K	268.53%76.24K	-3.17%46.71K	5.13%24.53K	5.13%24.53K	-63.82%23.91K	-4.41%20.69K	-36.68%48.24K	-58.02%23.33K	--23.33K
-Other receivables	-70.20%22.95K	5,467.33%222.69K	3,196.38%131.86K	1,825.43%77.02K	1,825.43%77.02K	0.00%4K	0.00%4K	0.00%4K	0.00%4K	--4K
-Recievables adjustments allowances	-134.02%-39.46K	---16.86K	---16.86K	---16.86K	---16.86K	----	----	----	----	----
Inventory	189.33%353.53K	-91.27%10.16K	-91.27%10.16K	5.03%122.19K	5.03%122.19K	92.16%218.13K	--116.34K	--116.34K	--116.34K	--116.34K
Prepaid assets	-65.85%59.15K	195.98%236.04K	365.83%129.07K	160.72%173.23K	160.72%173.23K	47.91%86.46K	-6.47%79.75K	261.02%27.71K	--66.44K	--66.44K
Total current assets	46.15%1.04M	-32.74%681.56K	-35.27%647.47K	-34.23%713.95K	-34.23%713.95K	-42.58%828.5K	-50.68%1.01M	-55.25%1M	-57.13%1.09M	--1.09M
Non current assets
Net PPE	-80.92%401	-57.30%1.26K	-50.41%1.67K	-44.67%2.1K	-44.67%2.1K	-39.90%2.53K	-36.56%2.95K	-33.80%3.38K	60.70%3.8K	--3.8K
-Gross PPE	0.00%5.66K	0.00%5.66K	0.00%5.66K	0.00%5.66K	0.00%5.66K	0.00%5.66K	0.00%5.66K	0.00%5.66K	112.07%5.66K	--5.66K
-Accumulated depreciation	-47.86%-5.26K	-62.60%-4.4K	-74.65%-3.98K	-91.38%-3.55K	-91.38%-3.55K	-116.18%-3.13K	-170.03%-2.7K	-310.07%-2.28K	-512.87%-1.86K	---1.86K
Goodwill and other intangible assets	9.31%1.85M	30.28%1.8M	28.88%1.74M	36.72%1.7M	36.72%1.7M	74.69%1.44M	135.37%1.38M	334.98%1.35M	378.12%1.24M	--1.24M
-Other intangible assets	9.31%1.85M	30.28%1.8M	28.88%1.74M	--1.7M	--1.7M	--1.44M	--1.38M	--1.35M	----	----
Total non current assets	9.20%1.85M	30.09%1.8M	28.68%1.74M	36.47%1.7M	36.47%1.7M	74.10%1.44M	134.02%1.38M	329.01%1.35M	375.26%1.24M	--1.24M
Total assets	20.13%2.9M	3.52%2.48M	1.48%2.39M	3.54%2.41M	3.54%2.41M	-0.02%2.27M	-9.41%2.4M	-7.77%2.35M	-16.60%2.33M	--2.33M
Liabilities
Current liabilities
Payables	14.08%358.19K	----	----	--313.98K	--313.98K	----	----	----	----	----
-accounts payable	14.08%358.19K	----	----	--313.98K	--313.98K	----	----	----	----	----
Current accrued expenses	-29.08%192.7K	----	----	--271.72K	--271.72K	----	----	----	----	----
Current deferred liabilities	-17.44%366K	18.56%399.07K	-12.24%283.19K	750.55%443.32K	750.55%443.32K	--387.58K	7,827.23%336.59K	7,501.32%322.68K	--52.12K	--52.12K
Current liabilities	-10.90%916.88K	50.98%1.14M	26.64%878K	142.82%1.03M	142.82%1.03M	171.51%812.35K	56.49%753.89K	417.80%693.3K	206.03%423.78K	--423.78K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-10.90%916.88K	50.98%1.14M	26.64%878K	142.82%1.03M	142.82%1.03M	171.51%812.35K	56.49%753.89K	417.80%693.3K	206.03%423.78K	--423.78K
Shareholders'equity
Share capital	10.80%5.69M	8.90%5.26M	8.90%5.26M	6.37%5.14M	6.37%5.14M	6.37%5.14M	0.00%4.83M	0.00%4.83M	120.03%4.83M	--4.83M
-common stock	10.80%5.69M	8.90%5.26M	8.90%5.26M	6.37%5.14M	6.37%5.14M	6.37%5.14M	0.00%4.83M	0.00%4.83M	120.03%4.83M	--4.83M
Additional paid-in capital	129.03%861.97K	-8.56%399.73K	-18.28%343.14K	-0.74%376.36K	-0.74%376.36K	46.32%371.09K	82.80%437.15K	103.73%419.9K	165.85%379.15K	--379.15K
Retained earnings	-19.93%-4.96M	-16.30%-4.32M	-8.27%-4.1M	-18.25%-4.13M	-18.25%-4.13M	-22.67%-4.05M	-19.90%-3.71M	-34.55%-3.78M	-39.28%-3.49M	---3.49M
Other equity interest	--380.58K	----	----	----	----	----	-54.14%87.26K	0.00%190.27K	-93.27%190.27K	--190.27K
Total stockholders'equity	43.21%1.98M	-18.25%1.34M	-9.03%1.51M	-27.42%1.38M	-27.42%1.38M	-26.05%1.46M	-24.09%1.64M	-31.35%1.66M	-28.21%1.91M	--1.91M
Total equity	43.21%1.98M	-18.25%1.34M	-9.03%1.51M	-27.42%1.38M	-27.42%1.38M	-26.05%1.46M	-24.09%1.64M	-31.35%1.66M	-28.21%1.91M	--1.91M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

MDMA Pharmala Biotech Holdings Inc

Pharmala Biotech Holdings Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow